Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 2, 2009, Pages 341-351

  Zhang, Zhi Yuan ^a   Zhang, Zhiren ^a   Fauser, Uwe ^a   Schluesener, Hermann J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

EAN; Inflammation; Minocycline; Neuropathic pain; Sciatic nerves

Indexed keywords

ANTIINFECTIVE AGENT; GELATINASE B; MINOCYCLINE;

ANIMAL; ARTICLE; BODY WEIGHT; DISEASE MODEL; ENZYMOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; INFLAMMATION; LYMPHOCYTE; MALE; METABOLISM; MONOCYTE; NEURITIS; PAIN; PATHOLOGY; RAT; SCIATIC NERVE;

ANIMALS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; DISEASE MODELS, ANIMAL; GUILLAIN-BARRE SYNDROME; HUMANS; INFLAMMATION; LYMPHOCYTES; MALE; MATRIX METALLOPROTEINASE 9; MINOCYCLINE; MONOCYTES; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PAIN; RATS; SCIATIC NERVE;

ANIMALIA; RATTUS;

EID: 61349195835     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00333.x     Document Type: Article

References (44)

1. Willison HJ. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst. 2005 10 : 94 112.
2. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005 366 : 1653 66.
3. Howarth AL. Pain management for multiple sclerosis patients. Prof Nurse. 2000 16 : 824 6.
4. Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today. 2000 6 : 88 91.
5. Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy. Brain Behav Immun. 2007 21 : 699 710.
6. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. Mechanical allodynia and spinal up-regulation of P2×4 receptor in experimental autoimmune neuritis rats. Neuroscience. 2007 doi: 10.1016/ j.neurosience. 2007.12.042.
7. Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist. 2005 11 : 308 22.
8. Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersen-sitivity in a rat model of neuropathy. J Pharmacol Exp Ther. 2003 306 : 624 30.
9. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain. 2005 115 : 71 83.
10. Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology. 2003 206 : 37 53.
11. Schluesener HJ, Seid K, Zhao Y, Meyermann R. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells. Glia. 1997 20 : 365 72.
12. Leifeld L, Fielenbach M, Dumoulin FL, Speidel N, Sauerbruch T, Spengler U. Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) expression in fulminant hepatic failure. J Hepatol. 2002 37 : 613 9.
13. Molander C, Xu Q, Grant G. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol. 1984 230 : 133 41.
14. Hartung HP, Schäfer B, Heininger K, Stoll G, Toyka KV. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations. Brain. 1988 111 : 1039 59.
15. Pannu R, Barbosa E, Singh AK, Singh I. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res. 2005 79 : 340 50.
16. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. FTY 720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration to peripheral nerves. Exp Neurol. 2008 210 : 681 90.
17. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002 39 : 279 91.
18. Kieseier BC, Clements JM, Pischel HB, Wells GM, Miller K, Gearing AJ, Hartung HP. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome. Ann Neurol. 1998 43 : 427 34.
19. Lee Y, Shin T. Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. J Neuroimmunol. 2002 126 : 78 85.
20. Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome. J Neuroimmunol. 1998 84 : 40 52.
21. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006 52 : 77 92.
22. Nasu-Tada K, Koizumi S, Tsuda M, Kunifusa E, Inoue K. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2×4, a key molecule for mechanical allodynia. Glia. 2006 53 : 769 75.
23. Schabet M, Whitaker JN, Schott K, Stevens A, Zürn A, Bühler R, Wiethölter H. The use of protease inhibitors in experimental allergic neuritis. J Neuroimmunol. 1991 31 : 265 72.
24. Mäurer M, Toyka KV, Gold R. Cellular immunity in inflammatory autoimmune neuropathies. Rev Neurol. 2002 158 : S7 15.
25. Kloppenburg M, Dijkmans BA, Verweij CL, Breedveld FC. Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocycline. Immunopharmacology. 1996 31 : 163 9.
26. Ingham E. Modulation of the proliferative response of murine thymocytes stimulated by IL-1, and enhancement of IL-1 beta secretion from mononuclear phagocytes by tetracyclines. J Antimicrob Chemother. 1990 26 : 61 70.
27. Parks WC, Wilson CL, López-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004 4 : 617 29.
28. Hughes PM, Wells GM, Clements JM, Gearing AJ, Redford EJ, Davies M, Smith KJ, Hughes RA, Brown MC, Miller KM. Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain. 1998 121 : 481 94.
29. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2001 2 : 502 11.
30. Lee MA, Palace J, Stabler G, Ford J, Gearing A, Miller K. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain. 1999 122 : 191 7.
31. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain. 2002 125 : 1297 308.
32. Newman JP, Verity AN, Hawatmeh S, Fee WE Jr., Terris DJ. Ciliary neurotrophic factors enhances peripheral nerve regeneration. Arch Otolaryngol Head Neck Surg. 1996 122 : 399 403.
33. Opdenakker G, Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol Today. 1994 15 : 103 7.
34. Zemke D, Majid A. The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol. 2004 27 : 293 8.
35. Saliba E, Henrot A. Inflammatory mediators and neonatal brain damage. Biol Neonate. 2001 79 : 224 7.
36. Hartung T, Döcke WD, Gantner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood. 1995 85 : 2482 9.
37. Abramson SB, Amin AR, Clancy RM, Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol. 2001 15 : 831 45.
38. Conti G, Rostami A, Scarpini E, Baron P, Galimberti D, Bresolin N, Contri M, Palumbo C, De Pol A. Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. Exp Neurol. 2004 187 : 350 8.
39. Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain-Barré syndrome. Neurology. 1997 48 : 328 31.
40. Ji RR, Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE. 2004 252 : reE14.
41. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002 82 : 981 1011.
42. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther. 2006 109 : 210 26.
43. Beiter T, Artelt MR, Trautmann K, Schluesener HJ. Experimental autoimmune neuritis induces differential microglia activation in the rat spinal cord. J Neuroimmunol. 2005 160 : 25 31.
44. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci. 2001 21 : 2580 8.